Stock comparison
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$104.11BHealthcare Market cap, Sector
Tandem Diabetes Care
TNDM$1.53BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
SANOFICONR.NS 70 TNDM
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
SANOFICONR.NS7wins
0winsTNDM
78B
F24
89A
B73
83B
F30
77B
D45
91A
F0
86A
F27
85A
F22
Side-by-side metrics
| Metric | SANOFICONR.NS | TNDM |
|---|---|---|
| Market cap | Winner: $104.11B | $1.53B |
| P/E (TTM) | 44.2x | - Winner |
| EV/EBIT | 31.8x | - Winner |
| ROIC (TTM) | Winner: 59.15% | -8.44% |
| Gross margin | Winner: 68.13% | 54.93% |
| Net margin | Winner: 27.35% | -9.2% |
| Revenue CAGR 5y | Winner: 27.01% | 9.62% |
| EPS CAGR 5y | 20.67% | - |
| Debt / Equity | Winner: 0.1x | 5.5x |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
SANOFICONR.NS leads on
- Net margin27.35%vs -9.2%+134%
- ROIC (TTM)59.15%vs -8.44%+114%
- Debt / Equity0.1xvs 5.5x+99%
- Market cap$104.11Bvs $1.53B+99%
TNDM leads on
- EV/EBIT-vs 31.8x+163%
- P/E (TTM)-vs 44.2x+124%
More like SANOFICONR.NS
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.